Structural differences between CVB5-P1anc and clinical CVB5 isolates. (A, left) A CVB3 (PDB accession number 1COV) (64) protomer in a ribbon diagram with VP1, VP2, VP3, and VP4 (light blue, light green, pink, and light yellow, respectively) with a symmetry-related copy of VP3 included to complete the canyon. Based on a ClustalW alignment of CVB5-P1anc and the CVB5 isolates with CVB3, the sequence-equivalent residues that differ between CVB5-P1anc and the CVB5 isolates are depicted as spheres, and VP1, VP2, VP3, and VP4 are shown in dark blue, green, red, and yellow, respectively. The asymmetric unit is indicated by a black triangle. (Right) A single pentamer of the virus capsid is surface rendered to show the location of the amino acid differences exposed to the viral surface. (B) Surface-rendered close-up of the pocket with VP1 residues 93 and 178 (i.e., residues 95 and 180 of CVB5) that line the pocket. The pocket factor is shown in orange (64). On the right is the pentamer showing the amino acid differences exposed to the interior surface of the capsid. (C) Residues predicted to interact with CAR and DAF. (Left) The protomer is shown in a ribbon diagram, with residues within the CAR and DAF footprints shown as magenta and cyan spheres (36, 39). A symmetry-related copy of VP3 is shown to provide the entire CAR footprint on CVB3 in one asymmetric unit. (Right) In the surface-rendered pentamer, the CAR footprint on CVB3 is in magenta, and the DAF binding footprint is in cyan.